Clinical Trials on Hyperlipoproteinemia Type 2
Total 57546 results
-
University of Texas Southwestern Medical CenterRecruitingType 1 HyperlipoprotenemiaUnited States
-
University of Texas Southwestern Medical CenterTerminatedType 1 HyperlipoproteinemiaUnited States
-
Nina HermansUniversity Hospital, AntwerpRecruitingLow-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaBelgium
-
S.LAB (SOLOWAYS)Center of New Medical Technologies; Triangel ScientificCompletedLDL Hyperlipoproteinemia | Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia | Triglyceride Storage Type I or II DiseaseRussian Federation
-
AstraZenecaCompletedHypertriglyceridemia | Hyperlipidemia | Hyperlipoproteinemia Type V | Hyperlipoproteinemia Type IV | Hyperlipoproteinemia Type IIbMexico
-
Hospices Civils de LyonCompleted
-
Technische Universität DresdenKaneka Pharma Europe N.V.RecruitingLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaGermany
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
Changi General HospitalNot yet recruitingCardiovascular Diseases | Hypercholesterolemia | Lipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaSingapore
-
UniQure Biopharma B.V.CompletedLipoprotein Lipase Deficiency | Familial Hyperlipoproteinemia Type 1 | Familial HyperchylomicronemiaGermany
-
Novartis PharmaceuticalsRecruitingHyperlipoproteinemia (a)Germany
-
Fresenius Medical Care Deutschland GmbHCompletedHypercholesterolemia, Familial | LIPOPROTEIN TYPES--Lp SYSTEM Lp(a) HYPERLIPOPROTEINEMIAGermany
-
Saint-Joseph UniversityUnknownDyslipidemias | LDL HyperlipoproteinemiaLebanon
-
Novartis PharmaceuticalsActive, not recruiting
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.Withdrawn
-
PfizerCompletedHypertriglyceridemia | Hyperlipoproteinemia Type IVUnited States, Canada
-
Hospices Civils de LyonCompletedHyperlipoproteinemia
-
Zhejiang UniversityUnknownHyperlipoproteinemiaChina
-
AstraZenecaCompleted
-
University of Texas Southwestern Medical CenterCompletedHypertriglyceridemia | Hyperlipoproteinemia Type IUnited States
-
Amsterdam Molecular TherapeuticsICON plcTerminatedHyperlipoproteinemia Type ICanada
-
PfizerTerminatedHyperlipoproteinemia Type IIICanada, United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | HyperlipoproteinemiaUnited States
-
Merck Sharp & Dohme LLCCompletedHyperlipoproteinemia Type II | Hypercholesterolemia, Familial
-
UMC UtrechtErasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsUnknownHyperlipoproteinemia Type III | Familial Dysbetalipoproteinemia
-
Eli Lilly and CompanyActive, not recruitingMetabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | HyperlipoproteinemiaUnited States, Mexico, Poland, Canada, Turkey, Japan, Argentina
-
Zhejiang UniversityCompletedHyperlipoproteinemiaChina
-
Zhejiang UniversityCompletedHyperlipoproteinemiaChina
-
Zhejiang UniversityCompletedHyperlipoproteinemia
-
University Hospital, BonnCompletedHypercholesterolemia | HyperlipoproteinemiaGermany
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1United States, Canada, Germany, Israel, Italy, South Africa, Spain, United Kingdom, Brazil, France, Netherlands
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1Canada
-
Organon and CoMerck Sharp & Dohme LLCCompletedAtherosclerosis | Hypercholesterolemia | Hyperlipoproteinemia Type II
-
Charite University, Berlin, GermanyWithdrawnHyperlipoproteinemia(a) | Progressive Cardiovascular DiseaseGermany
-
PfizerTIMI Study GroupCompletedDyslipidemias | Hyperlipidemias | HyperlipoproteinemiasUnited States, Canada, Poland
-
Merck Sharp & Dohme LLCTerminatedHyperlipoproteinemia Type II | Homozygous Familial Hypercholesterolemia
-
Yonsei UniversityDaewoong Pharmaceutical Co. LTD.RecruitingLow-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaKorea, Republic of
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Diseases | Coronary Disease | Hyperlipidemia, Familial Combined | Hyperlipoproteinemia Type iv
-
Catabasis PharmaceuticalsCompletedHypertriglyceridemia | Hyperlipoproteinemia Type I | Lipoprotein Lipase Deficiency, Familial | Chylomicronemia, FamilialCanada
-
Iuliu Hatieganu University of Medicine and PharmacyCompletedWeight Loss | Glucose, High Blood | LDL Hyperlipoproteinemia | HDL | Triglycerides High
-
Japan Tobacco Inc.CompletedType II HyperlipidaemiaNetherlands
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedCardiovascular Disease | Elevated Lipoprotein(a)United States, Canada, Denmark, Germany, Netherlands
-
NewAmsterdam PharmaActive, not recruitingDyslipidemias | Hypercholesterolemia | Hyperlipoproteinemias | Lipid Metabolism, Inborn Errors | Familial Hypercholesterolemia | Metabolic Disease | High Cholesterol | Genetic Disease, Inborn | Lipid Metabolism DisorderUnited States, Canada, Czechia, Georgia, Netherlands, Norway, Poland, South Africa, Spain, United Kingdom
-
Dr. Reddy's Laboratories LimitedPharmaNetCompletedType II HyperlipidemiaUkraine, Poland, Italy
-
Akros Pharma Inc.CompletedType II HyperlipidemiaNetherlands
-
Novartis PharmaceuticalsCompleted
-
Peking University Third HospitalNot yet recruitingFamilial Hypercholesterolemia
-
Poudre Valley Health SystemEnrolling by invitationFamilial HyperlipidemiaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHypercholesterolemia | Familial HypercholesterolemiaUnited States, Australia, Brazil, Canada, Chile, Colombia, Czechia, Finland, Hong Kong, Hungary, Israel, Netherlands, New Zealand, Norway, Singapore, Spain, Taiwan
-
Instituto de Seguridad y Servicios Sociales de...CompletedHypercholesterolemia, FamilialMexico